446 related articles for article (PubMed ID: 20172698)
1. Effect of molecular weight on the oleoyl-chitosan nanoparticles as carriers for doxorubicin.
Zhang J; Chen XG; Sun GZ; Huang L; Cheng XJ
Colloids Surf B Biointerfaces; 2010 Jun; 77(2):125-30. PubMed ID: 20172698
[TBL] [Abstract][Full Text] [Related]
2. Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin.
Zhang J; Chen XG; Li YY; Liu CS
Nanomedicine; 2007 Dec; 3(4):258-65. PubMed ID: 17962086
[TBL] [Abstract][Full Text] [Related]
3. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
Yu JM; Li YJ; Qiu LY; Jin Y
J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
[TBL] [Abstract][Full Text] [Related]
4. Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.
Fan L; Li F; Zhang H; Wang Y; Cheng C; Li X; Gu CH; Yang Q; Wu H; Zhang S
Biomaterials; 2010 Jul; 31(21):5634-42. PubMed ID: 20430433
[TBL] [Abstract][Full Text] [Related]
5. Doxorubicin-incorporated nanoparticles composed of poly(ethylene glycol)-grafted carboxymethyl chitosan and antitumor activity against glioma cells in vitro.
Jeong YI; Jin SG; Kim IY; Pei J; Wen M; Jung TY; Moon KS; Jung S
Colloids Surf B Biointerfaces; 2010 Aug; 79(1):149-55. PubMed ID: 20427160
[TBL] [Abstract][Full Text] [Related]
6. Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles.
Park K; Kim JH; Nam YS; Lee S; Nam HY; Kim K; Park JH; Kim IS; Choi K; Kim SY; Kwon IC
J Control Release; 2007 Oct; 122(3):305-14. PubMed ID: 17643545
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and characterization of amphiphilic glycidol-chitosan-deoxycholic acid nanoparticles as a drug carrier for doxorubicin.
Zhou H; Yu W; Guo X; Liu X; Li N; Zhang Y; Ma X
Biomacromolecules; 2010 Dec; 11(12):3480-6. PubMed ID: 21028798
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization novel polymer-coated magnetic nanoparticles as carriers for doxorubicin.
Li F; Sun J; Zhu H; Wen X; Lin C; Shi D
Colloids Surf B Biointerfaces; 2011 Nov; 88(1):58-62. PubMed ID: 21764271
[TBL] [Abstract][Full Text] [Related]
9. Glycyrrhetinic acid-modified chitosan/poly(ethylene glycol) nanoparticles for liver-targeted delivery.
Tian Q; Zhang CN; Wang XH; Wang W; Huang W; Cha RT; Wang CH; Yuan Z; Liu M; Wan HY; Tang H
Biomaterials; 2010 Jun; 31(17):4748-56. PubMed ID: 20303163
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles.
Hu FQ; Liu LN; Du YZ; Yuan H
Biomaterials; 2009 Dec; 30(36):6955-63. PubMed ID: 19782395
[TBL] [Abstract][Full Text] [Related]
11. Uptake of oleoyl-chitosan nanoparticles by A549 cells.
Zhang J; Chen XG; Peng WB; Liu CS
Nanomedicine; 2008 Sep; 4(3):208-14. PubMed ID: 18508414
[TBL] [Abstract][Full Text] [Related]
12. DNA/chitosan nanocomplex as a novel drug carrier for doxorubicin.
Cheng X; Zhang F; Zhou G; Gao S; Dong L; Jiang W; Ding Z; Chen J; Zhang J
Drug Deliv; 2009 Apr; 16(3):135-44. PubMed ID: 19514973
[TBL] [Abstract][Full Text] [Related]
13. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice.
Kim JH; Kim YS; Park K; Lee S; Nam HY; Min KH; Jo HG; Park JH; Choi K; Jeong SY; Park RW; Kim IS; Kim K; Kwon IC
J Control Release; 2008 Apr; 127(1):41-9. PubMed ID: 18234388
[TBL] [Abstract][Full Text] [Related]
14. Chitosan oligosaccharide-arachidic acid-based nanoparticles for anti-cancer drug delivery.
Termsarasab U; Cho HJ; Kim DH; Chong S; Chung SJ; Shim CK; Moon HT; Kim DD
Int J Pharm; 2013 Jan; 441(1-2):373-80. PubMed ID: 23174411
[TBL] [Abstract][Full Text] [Related]
15. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characteristics of chitosan microspheres in different acetylation as drug carrier system.
Wang AH; Chen XG; Liu CS; Meng XH; Yu le J; Wang H
J Microencapsul; 2009 Nov; 26(7):593-602. PubMed ID: 19839795
[TBL] [Abstract][Full Text] [Related]
17. Design and characterization of antitumor drug paclitaxel-loaded chitosan nanoparticles by W/O emulsions.
Xu J; Ma L; Liu Y; Xu F; Nie J; Ma G
Int J Biol Macromol; 2012 Mar; 50(2):438-43. PubMed ID: 22230611
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of N-succinyl-N'-octyl chitosan micelles as doxorubicin carriers for effective anti-tumor activity.
Xiangyang X; Ling L; Jianping Z; Shiyue L; Jie Y; Xiaojin Y; Jinsheng R
Colloids Surf B Biointerfaces; 2007 Apr; 55(2):222-8. PubMed ID: 17254755
[TBL] [Abstract][Full Text] [Related]
19. Cellular uptake and cytotoxicity of shell crosslinked stearic acid-grafted chitosan oligosaccharide micelles encapsulating doxorubicin.
Hu FQ; Wu XL; Du YZ; You J; Yuan H
Eur J Pharm Biopharm; 2008 May; 69(1):117-25. PubMed ID: 17997293
[TBL] [Abstract][Full Text] [Related]
20. Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: in vivo biodistribution and anti-tumor activity.
Hyung Park J; Kwon S; Lee M; Chung H; Kim JH; Kim YS; Park RW; Kim IS; Bong Seo S; Kwon IC; Young Jeong S
Biomaterials; 2006 Jan; 27(1):119-26. PubMed ID: 16023198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]